Actos Buyers Press 2nd Circ. To Revive Antitrust Claims
Buyers of the diabetes drug Actos urged the Second Circuit on Thursday to reinstate their antitrust case accusing Takeda Pharmaceuticals USA Inc. of delaying generic competition for the drug through false...To view the full article, register now.
Already a subscriber? Click here to view full article